Biotech | April 06, 2026
Biocon renames Irish step-down subsidiary as Biocon Biologics Ireland
Move aligns global biologics identity under the Biocon Biologics brand
Move aligns global biologics identity under the Biocon Biologics brand
Safety was equally impressive. ENV-294 was well tolerated
They also differentiated the innovator biologic Semaglutide molecule from newer synthetic or chemical generic versions entering the market
Minister highlights scope for domestic manufacturing during his meeting with Dr Niti Pall, President-elect, International Diabetes Federation
The record-setting effort stems from Danone India’s nationwide ‘IRON UP!’ campaign
The JADE trial enrolled 164 U.S. patients who initially received three monthly doses of OLN324 or faricimab, followed by 12 weeks off treatment with retreatment allowed only if disease recurred
71-year-old high-risk patient with atrial fibrillation and ventricular tachycardia discharged next day
The company has highlighted setbacks in Phase II studies while outlining fresh regulatory and late-stage development plans for Fibromun and Nidlegy
The company spotlights micronutrient’s role in immunity, skin and bone health through digital and radio outreach on National Vitamin C Day
Hands-on clinical workshop in Bengaluru brings together neurologists, ENT specialists and physicians
Subscribe To Our Newsletter & Stay Updated
